Latest filing published 27 Dec 2019 for Brainstorm Cell Therapeutics INC., €11k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +13.8%Entry US$64.35 · Close at T+365 US$73.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Arturo Araya: trading record in brief
This profile gathers the share dealings of Arturo Araya in Brainstorm Cell Therapeutics Inc. Between 26 February 2017 and 24 December 2019, the trades on record add up to 5 filings.
Every open-market trade on record is a purchase: 1 purchase worth €11k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 3 share grants. 2019 to date brings 1 purchase and no sales.
On 27 December 2019 came the latest disclosure, an open-market purchase for €11k in Brainstorm Cell Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Arturo Araya
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,000 shares@ US$3.90100.0% of flowCommon StockSEC:0001104659-19-076289:0Canonical exit: 23 Mar 2020 (T+90)
- 2,805 shares0Common StockSEC:0001144204-18-047847:0
- 1,249 shares0Common StockSEC:0001144204-18-016909:0
- 4,152 shares0Common StockSEC:0001144204-18-011819:0
- 3,012 shares0Common StockSEC:0001144204-17-012785:0
5 of 5 declarations